Bristol-Myers Squibb Dividend Announcement
Bristol-Myers Squibb declared a regular quarterly dividend in the amount of $.32 per share payable June 1, 2010 to shareholders of record on May 7, 2010.
At today''s $25.10 stock price the dividend yield is 5.10%.
Australia Court Dismisses Claims Against Merck
Today, the Federal Court in Australia dismissed all claims against Merck & Co., Inc. specifically finding that Merck was not negligent in its development, scientific study and sale of Vioxx.
The Court dismissed all claims against Merck & Co., Inc. specifically finding that Merck was not negligent in its development, scientific study and sale of Vioxx. Merck and MSD Australia disagree with the limited portions of the Court’s findings that were against MSD Australia and intend to appeal them.
J&J Reaffirms Fiscal 2010 Guidance
Reuters.com is reporting that Johnson & Johnson announced that for fiscal 2010, it continues to expect earnings of $4.85 to $4.95 per share. According to Reuters Estimates, analysts on an average are expecting the Company to report earnings per share (EPS) of $4.92 for fiscal 2010.
At today's stock price of about $63.80, with a 2010 EPS of $4.92 that results in a forward PE of about 13. That seems like a flat out steal of a valuation for J&J.
|Abbott's XIENCE PRIME Receives CE Mark (ABT)|
|Theraclone, Pfizer Ink Antibody Agreement (PFE)|
|Bristol-Myers Squibb Dividend Announcement (BMY)|
|Australia Court Dismisses Claims Against Merck (MRK)|
|J&J Reaffirms Fiscal 2010 Guidance (JNJ)|
|Abbott and GSK Team on Skin Cancer Test (ABT)|
|Pfizer and Medivation Alzheimer's Results (PFE)|
|J&J to Cut Bonus Targets for Some (JNJ)|
|Boston Scientific to Cut Over 1000 Jobs (BSX)|
|Genzyme Reports 4th Qtr and Full 2009 Results (GENZ)|
|Quest Diagnostics Declares Dividend (DGX)|
|Cephalon Record Sales and Adjusted Net Income (CEPH)|
|Merck Earnings Preview (MRK)|
|Boston Scientific 4th Qtr Results (BSX)|
|UnitedHealth Continues Dividend, Renews Buy Backs (UNH)|